Mg. Cheng et al., ASSEMBLY OF CYCLIN D-DEPENDENT KINASE AND TITRATION OF P27(KIP1) REGULATED BY MITOGEN-ACTIVATED PROTEIN-KINASE KINASE (MEK1), Proceedings of the National Academy of Sciences of the United Statesof America, 95(3), 1998, pp. 1091-1096
A constitutively active form of mitogen-activated protein kinase kinas
e (MEK1) was synthesized under control of a zinc-inducible promoter in
NIH 3T3 fibroblasts. Zinc treatment of serum-starved cells activated
extracellular signal-regulated protein kinases (ERKs) and induced expr
ession of cyclin D1. Newly synthesized cyclin D1 assembled with cyclin
dependent kinase-4 (CDK4) to form holoenzyme complexes that phosphory
lated the retinoblastoma protein inefficiently, Activation of the MEK1
/ERK pathway neither triggered degradation of the CDK inhibitor kinase
inhibitory protein-1 (p27(Kip1)) nor led to activation of cyclin E- a
nd A-dependent CDK2, and such cells did not enter the DNA synthetic (S
) phase of the cell division cycle. In contrast, zinc induction of act
ive MEK1 in cells also engineered to ectopically overexpress cyclin D1
and CDK4 subunits generated levels of cyclin D-dependent retinoblasto
ma protein kinase activity approximating those achieved in cells stimu
lated by serum. In this setting, p27(Kip1) was mobilized into complexe
s containing cyclin D1; cyclin E-and A-dependent CDK2 complexes were a
ctivated; and serum-starved cells entered S phase, Thus, although the
activity of p27(Kip1) normally is canceled through a serum-dependent d
egradative process, overexpressed cyclin D1-CDK complexes sequestered
p27(Kip1) and reduced the effective inhibitory threshold through a sto
ichiometric mechanism, A fraction of these cells completed S phase and
divided, but they were unable to continuously proliferate, indicating
that other serum-responsive factors ultimately became rate limiting f
or cell cycle progression, Therefore, the MEK/ERK pathway not only act
s transcriptionally to induce the cyclin D1 gene but functions posttra
nslationally to regulate cyclin D1 assembly with CDK4 and to thereby h
elp cancel p27(Kip1)-mediated inhibition.